Dubai, UAE – The World Health Exhibition 2026, held at Expo City Dubai, witnessed a wide display of the latest technical and therapeutic solutions provided by a group of specialized French companies.
In a strategic move that reflects a strong interest in expanding its presence in the region’s markets and strengthening cooperation frameworks with medical institutions in the UAE.
Mie Ghasham, Executive Officer in the Health Department at Business France, confirmed that participation this year focuses fundamentally on highlighting the diversity of French experiences.
Especially in the areas of biotechnology, medical supply chain management, digital transformation of health services, as well as introducing innovative solutions to raise the efficiency of medical facilities.
She noted that the exhibition represents a high-level international platform for dialogue on the future of healthcare and provides a strategic opportunity to hold direct meetings with decision-makers.
This contributes to building practical and sustainable partnerships, given the UAE’s dynamic market and openness to innovation.
This was evident in the great interaction witnessed by the French pavilion from major hospitals and government and private agencies.
In a review of the most prominent participating technologies, Anaïs David, CEO of Natiosanti, revealed that her company has developed advanced solutions aimed at improving air quality in health facilities to reduce transmission of infection and protect patients and medical personnel from biological and chemical pollutants.
She explained that the company focuses on air quality monitoring devices, independent purification systems, and advanced filtration technologies that keep pace with emerging health challenges and allow medical institutions to track air levels accurately and instantly.
Innovative solutions in neurorehabilitation
In parallel, Benjamin Maynard, Technical Director of F2D Medical, reviewed an innovative device that is the first of its kind to measure internal body temperature non-invasively through a system that relies on 11 sensors to measure multiple biomarkers.
He pointed out that the data is analyzed using algorithms supported by artificial intelligence to assess the risk of sepsis and its early detection.
Which enables doctors, especially in intensive care and oncology departments, to intervene therapeutically in a timely manner.
On the medical rehabilitation front, Alban De Luca, CEO and co-founder of ARCHONeon Medical, a French startup emerging from a university project in Saint-Etienne, presented innovative solutions in the field of neurorehabilitation based on the integration of motor and cognitive therapy using cameras and sensors.
He explained that the technology records the movement of the healthy part of the body and visually reflects it to stimulate the brain to restore motor functions in the affected limb.
Which enhances neural plasticity and accelerates the recovery of stroke patients with the aim of restoring their independence.
Innovative device to improve ventilation process
For his part, Davey Lunio, Vice President of Products and Co-Founder of DESSINTEY, discussed the development of a device to improve ventilation during cardiac arrest to ensure the optimal amount of oxygen reaches the brain at critical times.
He explained that clinical trials in Europe have proven that the device, which monitors the quality and rate of ventilation, can triple patients’ chances of survival in cases of cardiac arrest outside the hospital.
He pointed out that the company markets its products in 18 Western countries and has begun actual cooperation with ambulance services and some hospitals in the Emirates.
As it seeks through the exhibition to expand its partnerships in the Middle East and Asia.
